{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:51:17Z","timestamp":1783335077661,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000351","name":"Lung Foundation","doi-asserted-by":"crossref","award":["3.2.10.69"],"award-info":[{"award-number":["3.2.10.69"]}],"id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","award":["CTR 114696"],"award-info":[{"award-number":["CTR 114696"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fluidda"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foreest Medical School","award":["FIO 10-24"],"award-info":[{"award-number":["FIO 10-24"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.rmed.2017.07.064","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T14:15:46Z","timestamp":1501596946000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD"],"prefix":"10.1016","volume":"131","author":[{"given":"Hendrik J.","family":"Prins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-781X","authenticated-orcid":false,"given":"Ruud","family":"Duijkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Lutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"van der Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet","family":"Schoorl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib A.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjip S.","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim G.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2017.07.064_bib1","author":"From the Global Strategy for the Diagnosis"},{"issue":"9177","key":"10.1016\/j.rmed.2017.07.064_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","article-title":"Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial","volume":"354","author":"Davies","year":"1999","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.rmed.2017.07.064_bib3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","article-title":"Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans affairs cooperative study group","volume":"340","author":"Niewoehner","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2017.07.064_bib4","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"9","author":"Walters","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.rmed.2017.07.064_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9240","key":"10.1016\/j.rmed.2017.07.064_bib6","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rmed.2017.07.064_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2017.07.064_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/thoraxjnl-2012-202432","article-title":"TNFalpha antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial","volume":"68","author":"Aaron","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2017.07.064_bib9","first-page":"1","article-title":"Eosinophilia as marker of outcome in hospitalised patients with AECOPD","volume":"42","author":"Prins","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2017.07.064_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","article-title":"Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"2","author":"Brightling","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2017.07.064_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/resp.12724","article-title":"Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD","volume":"21","author":"Hasegawa","year":"2016","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.rmed.2017.07.064_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1183\/13993003.00436-2016","article-title":"What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion","volume":"48","author":"Sin","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2017.07.064_bib13","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/clind\/15.Supplement_1.S62","article-title":"Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious diseases society of america and the food and drug administration","volume":"15","author":"Chow","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2017.07.064_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.chest.2016.01.026","article-title":"Blood eosinophils and outcomes in severe hospitalised exacerbations of COPD","volume":"150","author":"Bafadhel","year":"2016","journal-title":"Chest"},{"issue":"9240","key":"10.1016\/j.rmed.2017.07.064_bib15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"issue":"6 Pt 1","key":"10.1016\/j.rmed.2017.07.064_bib16","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1164\/ajrccm.150.6.7952628","article-title":"Airway eosinophilia in chronic bronchitis during exacerbations","volume":"150","author":"Saetta","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2017.07.064_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","article-title":"Eosinophils in chronic obstructive pulmonary disease exacerbations are associated with increased readmissions","volume":"151","author":"Couillard","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.07.064_bib18","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2147\/COPD.S115132","article-title":"Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts","volume":"11","author":"Cheng","year":"2016","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"5","key":"10.1016\/j.rmed.2017.07.064_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","article-title":"Eosinophils: biological properties and role in health and disease","volume":"38","author":"Hogan","year":"2008","journal-title":"Clin. Exp. Allergy"},{"issue":"12","key":"10.1016\/j.rmed.2017.07.064_bib20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in\u00a0vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2017.07.064_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"J.\u00a0Pathol."},{"issue":"6","key":"10.1016\/j.rmed.2017.07.064_bib22","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.molimm.2006.05.002","article-title":"IgA is a more potent inducer of NADPH oxidase activation and degranulation in blood eosinophils than IgE","volume":"44","author":"Pleass","year":"2007","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.rmed.2017.07.064_bib23","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.4049\/jimmunol.161.8.4340","article-title":"Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils","volume":"161","author":"Motegi","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.rmed.2017.07.064_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2466-14-112","article-title":"COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils","volume":"14","author":"Eltboli","year":"2014","journal-title":"BMC Pulm. Med."},{"issue":"2\u20134","key":"10.1016\/j.rmed.2017.07.064_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000024040","article-title":"Regulation of IL-5 and IL-5 receptor expression in the bone marrow of allergic asthmatics","volume":"118","author":"Denburg","year":"1999","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2017.07.064_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2222.2011.03854.x","article-title":"Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor","volume":"42","author":"Molfino","year":"2012","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2017.07.064_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2249.1997.d01-884.x","article-title":"IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression","volume":"107","author":"Ochiai","year":"1997","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2017.07.064_bib28","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.4049\/jimmunol.164.7.3847","article-title":"Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines","volume":"164","author":"Shahabuddin","year":"2000","journal-title":"J.\u00a0Immunol."},{"issue":"6","key":"10.1016\/j.rmed.2017.07.064_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2017.07.064_bib30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0002-9343(81)90363-6","article-title":"Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis","volume":"71","author":"Shoenfeld","year":"1981","journal-title":"Am. J. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117302639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117302639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:38:21Z","timestamp":1760614701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611117302639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"alternative-id":["S0954611117302639"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.07.064","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.07.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}